These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26514457)

  • 21. Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion.
    Ryu KJ; Lee S; Min KJ; Kim JW; Hong JH; Song JY; Lee JK; Lee NW
    Oncologist; 2015 Jun; 20(6):635-9. PubMed ID: 25964305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer Screening Programme.
    Haldorsen T; Skare GB; Ursin G; Bjørge T
    Acta Oncol; 2015 Feb; 54(2):200-9. PubMed ID: 24957553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic evaluation of strategies for managing women with equivocal cytological results in Brazil.
    Vanni T; Legood R; Franco EL; Villa LL; Luz PM; Schwartsmann G
    Int J Cancer; 2011 Aug; 129(3):671-9. PubMed ID: 20886598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.
    Yan L; Xiao X; He L; Shi L; Yang X; Zhang J; Zhang Y; Fu C
    PLoS One; 2023; 18(3):e0282833. PubMed ID: 36913396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
    JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
    J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
    J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.
    ASCUS-LSIL Traige Study (ALTS) Group
    Am J Obstet Gynecol; 2003 Jun; 188(6):1383-92. PubMed ID: 12824967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Obesity in Persistent or Remission in Postmenopausal Women with Atypical Cervical Cytology.
    Phaliwong P; Luangdansakul W; Kornkarn Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3783-3787. PubMed ID: 31870122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
    Chatzistamatiou K; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Skenderi A; Stamatopoulos K; Agorastos T
    Gynecol Oncol; 2021 Sep; 162(3):560-568. PubMed ID: 34210517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of histopathologic/cytologic follow-up findings with vaginal ASC-US and ASC-H Papanicolaou test and HPV test results.
    Bansal M; Li Z; Zhao C
    Am J Clin Pathol; 2012 Mar; 137(3):437-43. PubMed ID: 22338056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical squamous cells of undetermined significance cervical cytology in the Chinese population: Age-stratified reporting rates, high-risk HPV testing, and immediate histologic correlation results.
    Tao X; Zhang H; Wang L; Pan Q; Ji S; Zhou X; Zhao C
    Cancer Cytopathol; 2021 Jan; 129(1):24-32. PubMed ID: 32697438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
    Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
    Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing.
    Cuzick J; Myers O; Lee JH; Shi Y; Gage JC; Hunt WC; Robertson M; Wheeler CM;
    JAMA Oncol; 2017 Oct; 3(10):1327-1334. PubMed ID: 28655061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study.
    Del Mistro A; Frayle-Salamanca H; Trevisan R; Matteucci M; Pinarello A; Zambenedetti P; Buoso R; Fantin GP; Zorzi M; Minucci D
    Gynecol Oncol; 2010 Apr; 117(1):77-81. PubMed ID: 20116836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
    Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation.
    Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Howard M; Roth P; Lorincz AT; Gafni A; Walter SD
    Arch Pathol Lab Med; 2003 Sep; 127(9):1169-75. PubMed ID: 12946228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.